Yüklüyor......
CAR-T cell therapy in ovarian cancer: from the bench to the bedside
Ovarian cancer (OC) is the most lethal gynecological malignancy and is responsible for most gynecological cancer deaths. Apart from conventional surgery, chemotherapy, and radiotherapy, chimeric antigen receptor-modified T (CAR-T) cells as a representative of adoptive cellular immunotherapy have rec...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5610030/ https://ncbi.nlm.nih.gov/pubmed/28969098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19929 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|